Printer Friendly Version
Douglas Gray is Chair of Locke Lord's Life Sciences Practice Group, focusing on medical device, pharmaceutical and health care-related companies and products. He brings to his clients a broad range of experience in the practice of corporate law, concentrating in the areas of mergers and acquisitions, corporate governance, strategic alliances and commercial ventures. In addition, he enjoys an active collaborations practice, centered on negotiating licensing, joint venture and development agreements relating to intellectual property rights. Douglas is a member of the Firm's Board of Directors and Co-Chairs the Firm's Pro Bono Committee.
News, Events, Notable Matters, and More
Showing Results for
Please understand that your communications with Locke Lord LLP through this website do not constitute or create an attorney-client relationship with Locke Lord LLP. Any information you send to Locke Lord LLP through this website is on a non-confidential and non-privileged basis. Therefore, do not send or include any information in your email that you consider to be confidential or privileged.